US-based pharmaceutical company Radient Pharmaceuticals Corporation announced Friday the Korean Food & Drug Administration (KFDA) has approved RPC’s Onko-Sure in Vitro Diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea.
CNNMoney